21 more people come under stray dog attacks in Kannur
Kannur: Amid growing public anger over the authorities' failure to address the stray dog menace in Kannur, 21 more people were attacked by stray dogs in the town on Wednesday. This comes just a day after nearly 50 people were bitten, triggering panic and widespread protests.
The latest attacks were reported from areas including Railway Station Road and SBI Junction. Most victims were elderly people and students, who suffered bite injuries on their legs and hands. All were treated with anti-rabies vaccines at various hospitals and later discharged.
The issue disrupted a council meeting of the Kannur corporation, with opposition councillors staging a protest. The meeting ended abruptly after mayor Muslif Madathil passed 74 agenda items without discussion.
Speaking to the media, the mayor blamed the LDF-led district panchayat, saying it failed to set up an animal birth control centre despite receiving Rs 20 lakh from the Corporation.
District panchayat president K K Rathna Kumari refuted the claim, calling it misleading. She said under the Kerala Municipal Act, the corporation is solely responsible for handling stray dog issues. She added that no funds were received from the corporation and the panchayat is working with local bodies to set up ABC centres.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
3 hours ago
- India Today
US judge strikes down Biden-era rule protecting privacy for abortions
A federal judge on Wednesday struck down a rule adopted by the administration of former President Joe Biden that strengthened privacy protections for women seeking abortions and patients who receive gender transition District Judge Matthew Kacsmaryk in Amarillo, Texas, said the US Department of Health and Human Services exceeded its powers and unlawfully limited states' ability to enforce their public health laws when it adopted the rule last rule prohibits healthcare providers and insurers from giving information about a legal abortion to state law enforcement authorities who are seeking to punish someone in connection with that abortion. "HHS lacked clear delegated authority to fashion special protections for medical information produced by politically favoured medical procedures," wrote Kacsmaryk, who was appointed by President Donald Trump, a Republican, during his first in December blocked HHS from enforcing the rule against a Texas doctor who had brought the lawsuit, Carmen Purl, pending the outcome of the case. Wednesday's decision blocks the rule did not immediately respond to a request for is represented by Alliance Defending Freedom, a conservative Christian legal group. Matt Bowman, senior counsel with the group, praised the decision in a statement, saying the 2024 rule "would have weaponised laws about privacy that have nothing to do with abortion or gender identity."advertisementThe Biden administration issued the rule as part of its pledge to support access to reproductive healthcare after the conservative-majority US Supreme Court in 2022 overturned the 1973 Roe v. Wade ruling that made access to abortion a constitutional right came in response to efforts by authorities in some Republican-led states that ban abortion, including Texas, to restrict out-of-state travel for has filed a separate lawsuit challenging the rule, which is pending in federal court in Lubbock, Texas. HHS in a court filing last month said agency leadership appointed by Trump is evaluating its position in this a Democrat, said in announcing the rule that no one should have their medical records "used against them, their doctor, or their loved one just because they sought or received lawful reproductive health care."Must Watch
Time of India
5 hours ago
- Time of India
Centre extends deadline for revised Schedule M implementation for small, medium pharmas
Mysuru: The Union govt has extended the deadline for implementing the revised Schedule M–Good Manufacturing Practices (GMP)–for small and medium pharmaceutical enterprises (SMEs) with an annual turnover of Rs 250 crore or less, until the end of this year, said Khalid Ahmed Khan, deputy drug controller and president of the Indian Pharmaceutical Association (IPA), Karnataka state branch. He was speaking at the inauguration of a national conference on 'Enhancing Pharmaceutical Quality Assurance through Good Manufacturing Practices (GMP)' and a special session on the Revamped Pharmaceutical Technology Upgradation Assistance Scheme. The event was organised by the PHD Chamber of Commerce and Industry (PHDCCI) health committee in association with the department of pharmaceuticals, Union ministry of chemicals and fertilizers, JSS Academy of Higher Education and Research (JSS AHER) and the IPA Mysuru branch, at the JSS College of Pharmacy on Wednesday. Khan noted that due to the financial burden involved in implementing the revised quality framework, MSME firms were granted time until Dec 2025 to comply. "Firms with turnover above Rs 250 crore, as well as all newly established plants, are required to adopt the revised Schedule M immediately. These guidelines are aligned with WHO and international standards and emphasise total quality management and robust pharmaceutical systems," he added. Khan stressed the importance of leadership and a quality-driven mindset in the pharmaceutical sector. "Even if you're not in a leadership position, you can influence those who are. Without quality, neither the industry nor its workforce can sustain," he said. Dr H Basavana Gowdappa, VC, JSS AHER, commended the department of pharmaceuticals for launching the RPTUAS and urged the industry to treat GMP not as a regulation but a fundamental responsibility. Amaresh Tumbagi, former drug controller of Karnataka, outlined the inspection mechanisms under the revised Schedule M and how regulatory processes have evolved. Dr Pramod Kumar TM, principal, JSS College of Pharmacy, provided insights into current industry regulations and compliance requirements. Jatin Nagpal, joint secretary, PHDCCI, Dharmendra Kumar Yadav, under secretary, department of pharmaceuticals, Yashwant Shinde, manager, SIDBI and Dr Savitha RS, secretary, IPA Mysuru local branch were also present.
The Hindu
9 hours ago
- The Hindu
U.S. top court upholds ban on gender-affirming care for minors
The U.S. Supreme Court on Wednesday (June 18, 2025) upheld a state law banning gender-affirming medical treatments for transgender minors – an issue at the heart of the American culture wars. The court voted 6-3 to uphold a Tennessee law barring hormone therapy, puberty blockers and gender transition surgery for those under the age of 18. The six conservative justices on the top court rejected a challenge to the law while the three liberals dissented. Two dozen Republican-led states have enacted laws restricting medical care for transgender youth, and the case will have repercussions for the prohibitions across the country. 'This case carries with it the weight of fierce scientific and policy debates about the safety, efficacy, and propriety of medical treatments in an evolving field,' wrote Chief Justice John Roberts, author of the majority opinion. 'The Court's role is not 'to judge the wisdom, fairness, or logic' (of the law) but only to ensure that the law does not violate equal protection guarantees,' Mr. Roberts said. 'It does not. Questions regarding the law's policy are thus appropriately left to the people, their elected representatives, and the democratic process,' he added. The Supreme Court heard the case in December, and the Justice Department of then-president Joe Biden joined opponents of the law, arguing that it violated the Constitution's Equal Protection Clause since it denies transgender minors access to medical treatments permitted to others. Republican President Donald Trump has since taken office, and he signed an executive order in January restricting gender transition procedures for people under the age of 19. While there is no U.S.-wide law against gender-affirming medical treatments for transgender youth, the Mr. Trump order ended any federal backing for such procedures. Reacting to the ruling, the American Academy of Pediatrics (AAP) said it 'sets a dangerous precedent for legislative interference in the practice of medicine.' 'Gender-affirming care is medically necessary for treating gender dysphoria and is backed by decades of peer-reviewed research, clinical experience, and scientific consensus,' the AAP said. 'Denying patients access to this care not only undermines their health and safety, but it also robs them of basic human dignity.' 'Must end' The Alliance Defending Freedom, a conservative legal group, welcomed the ruling as a 'huge win for children' and a 'step toward ending dangerous experiments on kids.' During oral arguments in December, Tennessee Solicitor General Matthew Rice told the court the law was designed to 'protect minors from risky, unproven medical interventions' with 'often irreversible and life-altering consequences.' Chase Strangio, an American Civil Liberties Union attorney representing three transgender adolescents, their parents, and a Memphis-based doctor, countered that the law has 'taken away the only treatment that relieved years of suffering.' 'What they've done is impose a blunderbuss ban, overriding the very careful judgment of parents who love and care for their children and the doctors who have recommended the treatment,' said Mr. Strangio, the first openly transgender lawyer to argue before the court. Mr. Trump, in his inauguration speech, said his government would henceforth only recognise two genders – male and female – and he issued his executive order a week later restricting gender transition procedures for minors. 'Across the country today, medical professionals are maiming and sterilising a growing number of impressionable children,' the executive order said. 'This dangerous trend will be a stain on our Nation's history, and it must end.' Mr. Trump's order said it would now be U.S. policy that it would 'not fund, sponsor, promote, assist, or support the so-called 'transition' of a child from one sex to another.' The order bars funding for gender transition under the Medicaid health insurance program for poor families, the Medicare scheme used by retirees, and Defense Department health insurance that covers some two million children. According to a study by UCLA's Williams Institute, an estimated 1.6 million people aged 13 and older in the United States identify as transgender.
